Listed by the USPTO as MCMILLIAN, KARA RENITA
Tech Center 1600 • Art Units: 1617 1622 1623 1627
This examiner grants 31% of resolved cases
MCMILLIAN, KARA RENITA is assigned to Tech Center 1600 and art unit 1617. The profile contains 983 resolved cases, with an allowance rate of 30.9%. The median time to allowance is 1341 days, indicating both a low allowance outcome and a prolonged path for cases that reach allowance. The substantial docket makes the pattern important for prosecution planning.
The interview lift is 37.9%, associating interviews with improved allowance outcomes despite the overall allowance rate. Counsel may use interviews to clarify the examiner's position and develop targeted amendments, while preparing for sustained written prosecution. The leading companies are Zedira GmbH, The Brigham and Women's Hospital Inc., and Merck Patent GmbH. The leading firms are BakerHostetler, Knobbe, Martens, Olson & Bear, LLP, and BIRCH STEWART KOLASCH & BIRCH, LLP.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17250489 | TLR7/8 ANTAGONISTS AND USES THEREOF | Final Rejection | Merck Patent GmbH |
| 18027255 | IMMUNOLOGICAL EFFECTS OF METABOLITES | Final Rejection | The Regents of the University of California |
| 19303084 | SOLID R-BETA-HYDROXYBUTYRIC ACID COMPOSITION | Non-Final OA | AXCESS GLOBAL SCIENCES, LLC |
| 18458702 | PERSONAL CARE COMPOSITIONS | Final Rejection | Colgate-Palmolive Company |
| 17783220 | PARASITE CONTROL IN RUMINANTS | Final Rejection | Intervet Inc. |
| 17616248 | NOVEL SPIROBICYCLIC INTERMEDIATES | Non-Final OA | Janssen Pharmaceutica NV |
| 18838503 | ANTICANCER DRUG AND ANTICANCER DRUG SCREENING METHOD | Non-Final OA | Kyushu University, National University Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy30.9% of resolved applications examined by Kara Renita Mcmillian were allowed (983 resolved cases), compared with 34.1% across Art Unit 1617 over the last five years.
This examiner's interview lift is +37.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kara Renita Mcmillian took 1,341 days on average from filing to allowance.
Kara Renita Mcmillian examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
